Skip to content

Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma

Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00322855
Enrollment
1
Registered
2006-05-08
Start date
2005-08-31
Completion date
2007-08-31
Last updated
2015-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoma

Brief summary

To review the outcome of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005.

Detailed description

Chart review of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005 to determine outcome

Interventions

None listed

Sponsors

New Mexico Cancer Research Alliance
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.

Exclusion criteria

* Not Specified

Design outcomes

Primary

MeasureTime frame
To Review the Outcome of Patients With Soft Tissue Sarcoma Treated With Chemotherapy From 2004 and 2005up to one year

Countries

United States

Participant flow

Participants by arm

ArmCount
Chart Review
patients diagnosed with soft tissue sarcoma
1
Total1

Baseline characteristics

CharacteristicChart Review
Age, Continuous17 years
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

To Review the Outcome of Patients With Soft Tissue Sarcoma Treated With Chemotherapy From 2004 and 2005

Time frame: up to one year

Population: Study was terminated due to low accrual. This is not an applicable trial; no results to report

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026